Apollo-Backed Novolex to Buy Pactiv Evergreen for $3.22 Billion; Deal, valued at $6.7 billion including debt, is slated to close in mid-2025

Saved in:
Bibliographic Details
Published in:The Wall Street journal. Eastern edition 2024-12-09
Main Author: Kellaher, Colin
Format: Newspaper Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2574-9579